These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24293577)

  • 1. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
    Kim A; Marinkovich N; Vasquez R; Jacobe HT
    J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Evaluation of the Performance of Current Morphea Subtype Classifications.
    Prasad S; Zhu JL; Schollaert-Fitch K; Torok KS; Jacobe HT
    JAMA Dermatol; 2021 Apr; 157(4):1-8. PubMed ID: 33595618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disabling pansclerotic morphea of children.
    Diaz-Perez JL; Connolly SM; Winkelmann RK
    Arch Dermatol; 1980 Feb; 116(2):169-73. PubMed ID: 7356347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disabling pansclerotic morphea of childhood--unusual case and management challenges.
    Forsea AM; Cretu AN; Ionescu R; Giurcaneanu C
    J Med Life; 2008; 1(3):348-54. PubMed ID: 20108512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort.
    Prasad S; Black SM; Zhu JL; Sharma S; Jacobe H
    J Am Acad Dermatol; 2021 Jul; 85(1):114-120. PubMed ID: 33249064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disabling pansclerotic morphea: clinical presentation in two adults.
    Maragh SH; Davis MD; Bruce AJ; Nelson AM
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S115-9. PubMed ID: 16021158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Disease Activity and Damage Over Time in Patients With Morphea.
    O'Brien JC; Nymeyer H; Green A; Jacobe HT
    JAMA Dermatol; 2020 May; 156(5):513-520. PubMed ID: 32236501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.
    Ventéjou S; Schwieger-Briel A; Nicolai R; Christen-Zaech S; Schnider C; Hofer M; Bogiatzi S; Hohl D; De Benedetti F; Morren MA
    Front Immunol; 2021; 12():656407. PubMed ID: 33767715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.
    Kunzler E; Florez-Pollack S; Teske N; O'Brien J; Prasad S; Jacobe H
    J Am Acad Dermatol; 2019 Jun; 80(6):1664-1670.e1. PubMed ID: 31005342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin mapping for the classification of generalized morphea.
    Teske N; Welser J; Jacobe H
    J Am Acad Dermatol; 2018 Feb; 78(2):351-357. PubMed ID: 29332706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association.
    Devidayal ; Singh S; Kumar L; Radotra BD
    Rheumatol Int; 2002 Jan; 21(4):158-60. PubMed ID: 11843172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pansclerotic morphea with features of eosinophilic fasciitis: distinct entities or part of a continuum?
    Odhav A; Hoeltzel MF; Canty K
    Pediatr Dermatol; 2014; 31(2):e42-7. PubMed ID: 24383741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.
    Martini G; Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F
    Autoimmun Rev; 2018 Jul; 17(7):727-734. PubMed ID: 29729451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pansclerotic morphea with a rapidly fatal outcome in an 11-year-old girl].
    Hardy J; Audouin-Pajot C; Abid A; Chiotasso D; Coustets B; Suc A; Timsit P; Mouthon L; Mazereeuw-Hautier J
    Ann Dermatol Venereol; 2016 Dec; 143(12):836-840. PubMed ID: 27496274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV.
    Grabell D; Hsieh C; Andrew R; Martires K; Kim A; Vasquez R; Jacobe H
    J Am Acad Dermatol; 2014 Sep; 71(3):493-8. PubMed ID: 24880663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
    Johnson W; Jacobe H
    J Am Acad Dermatol; 2012 Nov; 67(5):881-9. PubMed ID: 22382198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep morphea.
    Bielsa I; Ariza A
    Semin Cutan Med Surg; 2007 Jun; 26(2):90-5. PubMed ID: 17544960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pansclerotic morphea: A male child with hemiatrophy of lower limb.
    Dasgupta MK; Patra C; Sarkar S; Das S
    Indian Dermatol Online J; 2014 Apr; 5(2):170-2. PubMed ID: 24860754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of self-reported quality of life in adults and children with morphea.
    Das S; Bernstein I; Jacobe H
    J Am Acad Dermatol; 2014 May; 70(5):904-10. PubMed ID: 24534655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.
    Dharamsi JW; Victor S; Aguwa N; Ahn C; Arnett F; Mayes MD; Jacobe H
    JAMA Dermatol; 2013 Oct; 149(10):1159-65. PubMed ID: 23925398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.